M&A Shows Signs of Covid Comeback with Hopes of Record Drug Deal

Published June 7, 2020

The prospect of a record tie-up in the global health-care industry is helping stir dealmakers’ confidence that mergers and acquisitions activity can rebound from its deep coronavirus slump.

Related Stories